Baker Bros. Advisors »

Avalo Therapeutics Ord shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $10M 550k 18.48

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Revolution Medicines (RVMD)
Madrigal Pharmaceuticals (MDGL)
ACADIA Pharmaceuticals (ACAD)
Kymera Therapeutics (KYMR)
Insmed Incorporated Com Par $.01 (INSM)
Celcuity (CELC)
Kodiak Sciences (KOD)
Rhythm Pharmaceuticals (RYTM)
Praxis Precision Medicines I (PRAX)
Alkermes SHS (ALKS)
Summit Therapeutics (SMMT)
Grail (GRAL)
Abcellera Biologics (ABCL)

View all positions for Baker Bros. Advisors

Top funds holding Avalo Therapeutics Ord

FMR
BlackRock
Deep Track Capital
Caligan Partners
TCG Crossover Management
Affinity Asset Advisors
Farallon Capital Management
Point72 Asset Management
venBio Select Advisor
Vanguard Capital Management
BVF
Bank of America Corporation
Nantahala Capital Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Avalo Therapeutics Ord